Recombinant Mouse KiSS-1 receptor (Kiss1r)

What is the Kiss1/Kiss1r system and what is its primary physiological role?

The Kiss1/Kiss1r system consists of kisspeptin (encoded by the Kiss1 gene) and its receptor KISS1R (encoded by the Kiss1r gene). This system serves as an essential regulator of reproductive function in mammals. Loss-of-function mutations in either Kiss1 or Kiss1r genes in both humans and mice result in hypogonadotropic hypogonadism, characterized by abnormal sexual maturation and decreased circulating levels of sex steroids and gonadotropins .

The primary physiological role of the Kiss1/Kiss1r system appears to be the regulation of gonadotropin-releasing hormone (GnRH) secretion. Administration of kisspeptins induces a rapid increase in luteinizing hormone (LH) secretion through direct action on GnRH neurons . Additionally, the Kiss1/Kiss1r system is critical for sexual maturation, as both Kiss1r and Kiss1 expression increases during puberty, and administration of kisspeptin to juvenile rodents can precipitate puberty onset .

Where is Kiss1r expressed in mouse tissues?

Kiss1r shows a diverse expression pattern across multiple mouse tissues:

• Central Nervous System: Kiss1r is expressed in the hypothalamus, particularly in GnRH neurons .

• Reproductive Tissues: Western blot analysis using specific anti-KISS1R antibodies has demonstrated KISS1R expression in the testes and epididymis .

• Seminiferous Tubules: Immunohistochemical studies reveal that KISS1R is present in the seminiferous tubules from postnatal week 3 to week 12, with clear localization on the cell membrane of round spermatids at 1000× magnification .

• Bone Marrow: KISS1R is upregulated on mesenchymal stem cells (MSCs) and osteoprogenitor cells (OPCs) when co-cultured with myeloma cells .

Interestingly, KISS1R expression patterns may vary by species, life stage, and pathological status .

How does Kiss1r signaling function at the cellular level?

Kiss1r is a G-protein-coupled receptor that, when activated by kisspeptin, initiates several signaling cascades. In testicular development, luteinizing hormone (LH) appears to act as an upstream initiator to induce Kiss1 expression in mouse Leydig cells through the cAMP/PKA pathway .

The temporal relationship between Kiss1r signaling and other developmental factors is notable. Research shows that the expression levels of Insl3, Cyp19a1, and Kiss1 genes increase simultaneously after increased expression of the LH receptor gene (Lhcgr) . This synchronized expression pattern suggests that Kiss1r signaling works in concert with other developmental regulators.

In neuronal populations, Kiss1r activation in GnRH neurons leads to increased electrical activity and hormone release. The electrophysiological responses of GnRH neurons to kisspeptin increase across puberty, indicating developmental regulation of this signaling pathway .

What phenotypes are observed in Kiss1r knockout mouse models?

Kiss1r knockout mice exhibit several distinct phenotypes:

• Reproductive Development: These mice are infertile due to hypogonadotropic hypogonadism .

• Sexual Maturation: They show abnormal sexual maturation with impaired development of secondary sexual characteristics .

• Hormone Levels: Decreased circulating levels of sex steroids and gonadotropins are observed .

• Puberty: They fail to undergo normal pubertal development and remain in a prepubertal state .

These phenotypes closely mirror those observed in humans with loss-of-function mutations in KISS1R, highlighting the evolutionary conservation of this system's reproductive functions.

What are the optimal methods for generating recombinant mouse Kiss1r for in vitro studies?

For generating recombinant mouse Kiss1r protein for in vitro studies, researchers should consider:

Expression System Selection:

• Mammalian expression systems (e.g., HEK293 or CHO cells) are preferred for producing functional Kiss1r with proper post-translational modifications.

• Baculovirus expression systems can also yield high quantities of functional receptor protein.

Vector Design Considerations:

• Include an N-terminal signal sequence to ensure proper membrane targeting.

• Consider adding epitope tags (e.g., FLAG, His, or HA) for easy detection and purification, but verify tag positioning doesn't interfere with ligand binding.

• For functional studies, fluorescent protein fusions (GFP/RFP) can be employed to track receptor localization.

Purification Strategy:

• For membrane proteins like Kiss1r, detergent solubilization followed by affinity chromatography is typically employed.

• Consider using stabilizing agents during purification to maintain receptor conformation.

Functional Validation:

• Confirm ligand binding using radiolabeled or fluorescently-labeled kisspeptin.

• Verify downstream signaling activation through cAMP/PKA pathway assessment .

How can one effectively visualize Kiss1r-expressing cells in mouse tissue samples?

Based on published methodologies, effective visualization of Kiss1r-expressing cells can be achieved through:

Immunohistochemistry (IHC):

• Generate specific anti-KISS1R antibodies. For example, one study successfully produced an anti-KISS1R immunoglobulin Y antibody for KISS1R identification .

• Verify antibody specificity through Western blot analysis against tissues known to express Kiss1r (hypothalamus, testis) versus negative controls.

• Use appropriate dilution ratios (e.g., 1:800,000 as reported in one study) to achieve specific signal while minimizing background .

• Include tissue-specific positive controls, such as hypothalamus for KISS1R detection.

• Implement adsorption tests by preincubating antibodies with immunogenic peptides to confirm specificity .

Transgenic Reporter Systems:

• Utilize Kiss1-Cre transgenic mice crossed with reporter mice expressing Cre-dependent fluorescent proteins or β-galactosidase .

• This approach allows visualization of cells that express or have expressed Kiss1r during development.

Fluorescent Ligand Binding:

• Conjugate kisspeptin with fluorescent dyes for both in vitro and in vivo visualization.

• This approach has successfully demonstrated binding to Kiss1r-expressing cells in multiple myeloma models .

What are the challenges in characterizing Kiss1r-ligand interactions in vivo?

Characterizing Kiss1r-ligand interactions in vivo presents several methodological challenges:

Receptor Dynamics and Trafficking:

• Kiss1r undergoes internalization upon ligand binding, complicating real-time tracking of receptor-ligand interactions.

• Developing methods to distinguish between membrane-bound and internalized receptors is essential.

Tissue-Specific Expression Patterns:

• Kiss1r expression varies across tissues and developmental stages, requiring careful experimental design.

• The receptor shows inconsistent localization patterns between studies, with some reporting expression in spermatid acrosomes and others on spermatid membranes .

Ligand Stability and Bioavailability:

• Kisspeptin has a short half-life in circulation, limiting exposure time for interaction studies.

• Consider using kisspeptin analogs with enhanced stability for in vivo studies.

Downstream Signaling Verification:

• Validation that observed ligand binding activates physiologically relevant signaling pathways is essential.

• The cAMP/PKA pathway appears to be particularly important for Kiss1r signaling in testicular cells .

How can Kiss1r be used as a biomarker in disease models such as multiple myeloma?

Kiss1r shows promise as a biomarker in disease models, particularly multiple myeloma:

Dual Targeting Capability:

• Kiss1r is upregulated on both myeloma cells and cells of the tumor microenvironment (mesenchymal stem cells and osteoprogenitor cells) .

• This dual expression pattern makes it particularly valuable as it can target both the malignant cells and the surrounding microenvironment.

In Vivo Imaging Applications:

• Fluorescently-labeled kisspeptin has been used successfully for in vivo imaging of myeloma bone lesions.

• Studies show increased peak fluorescence in tumor-burdened limbs compared to contralateral controls after injection of conjugated kisspeptin .

Methodological Approach:

• Generate fluorescently-labeled kisspeptin conjugates (e.g., with near-infrared fluorophores for in vivo applications).

• Validate binding specificity in vitro using cell lines with confirmed Kiss1r expression.

• For in vivo studies, inject conjugated kisspeptin into disease model mice.

• Compare signal intensity between affected and unaffected tissues.

• Confirm specificity through competition with unlabeled kisspeptin.

This approach offers potential for both diagnostic applications and for monitoring disease progression or treatment response in preclinical models.

What are the best transgenic mouse models available for studying Kiss1r function?

Several transgenic mouse models have been developed to study Kiss1r function:

Kiss1-Cre Transgenic Models:

• These models express Cre recombinase under the control of the Kiss1 promoter.

• Line J2-4 has been reported to show Cre activity specifically within Kiss1 neurons .

• When crossed with reporter mice, they allow visualization of Kiss1-expressing cells through Cre-dependent expression of green fluorescent protein (GFP) or β-galactosidase (βGal) .

Reporter Lines for Kiss1r Visualization:

• Reporter mice with Cre-dependent expression systems can be used to mark the location of Kiss1 neurons.

• These models facilitate studies of Kiss1 neuron development, connectivity, and function .

Conditional Knockout Models:

• Floxed Kiss1r alleles combined with tissue-specific Cre expression allow selective deletion of Kiss1r in specific cell types.

• These models are valuable for dissecting cell-autonomous versus non-cell-autonomous functions of Kiss1r.

Point Mutation Models:

• Models with specific mutations in Kiss1r that affect ligand binding or signaling can help elucidate structure-function relationships.

• These are particularly useful for studying the consequences of human disease-associated mutations.

How can one quantify changes in Kiss1r expression in response to hormonal stimulation?

Quantifying changes in Kiss1r expression following hormonal stimulation requires reliable methodologies:

Quantitative Real-Time PCR (qRT-PCR):

• Extract total RNA from tissues of interest using standard protocols.

• Perform reverse transcription to generate cDNA.

• Design primers specific to Kiss1r mRNA.

• Include appropriate housekeeping genes (e.g., Rpl19 has been used successfully) for normalization .

• Express results as fold changes compared to baseline or control conditions.

• This approach has successfully demonstrated that Kiss1r mRNA is constitutively expressed in mouse testes from week 0 to 12 .

Western Blot Analysis:

• Extract protein samples from tissues using appropriate buffers.

• Separate proteins by SDS-PAGE and transfer to membranes.

• Probe with validated anti-KISS1R antibodies.

• KISS1R typically presents as a band at 43 kDa .

• Include positive controls (e.g., hypothalamus) and negative controls.

• Perform densitometric analysis to quantify changes.

Cell Culture Models for Direct Hormone Effects:

• Primary mouse Leydig cells treated with LH and MA-10 cells treated with Br-cAMP have shown increased Kiss1 mRNA expression .

• Cotreatment with protein kinase A inhibitor RP-cAMP significantly suppressed Br-cAMP-induced Kiss1 expression, confirming pathway specificity .

What methods are most effective for studying Kiss1r signaling in specific neuronal populations?

For studying Kiss1r signaling in specific neuronal populations, several sophisticated methods are available:

Electrophysiological Approaches:

• Patch-clamp recording can measure direct neuronal responses to kisspeptin stimulation.

• This approach has revealed that GnRH neurons show increased electrophysiological responses to kisspeptin across puberty .

Calcium Imaging:

• Load neurons with calcium-sensitive dyes or express genetically-encoded calcium indicators.

• Monitor changes in intracellular calcium in response to kisspeptin stimulation.

• This approach can be used in acute brain slices or primary neuronal cultures.

Single-Cell Transcriptomics:

• Isolate specific neuronal populations using fluorescence-activated cell sorting (FACS) or laser capture microdissection.

• Perform single-cell RNA sequencing to identify co-expressed genes and signaling pathways.

• This approach can reveal heterogeneity within Kiss1r-expressing neuronal populations.

Chemogenetic and Optogenetic Approaches:

• Express designer receptors exclusively activated by designer drugs (DREADDs) or light-sensitive channels in Kiss1r-expressing neurons.

• Selectively activate or inhibit these neurons to assess downstream effects on GnRH secretion and reproductive function.

How can one assess the functional consequences of Kiss1r mutations?

Assessing the functional consequences of Kiss1r mutations requires a multi-level approach:

In Vitro Receptor Function Assays:

• Express wild-type and mutant Kiss1r in heterologous cell systems.

• Measure ligand binding using labeled kisspeptin.

• Assess downstream signaling activation (cAMP, calcium mobilization, ERK phosphorylation).

• Quantify receptor internalization and trafficking.

• Determine EC50 values to measure potency changes.

Knock-in Mouse Models:

• Generate mice carrying specific Kiss1r mutations using CRISPR/Cas9 technology.

• Assess reproductive phenotypes:

  • Puberty onset timing

  • Fertility

  • Gonadal development

  • Hormone levels (LH, FSH, sex steroids)

• Evaluate hypothalamic-pituitary-gonadal axis function through hormone challenge tests.

Ex Vivo Tissue Function:

• Prepare hypothalamic slices from mutant mice.

• Measure electrophysiological responses of GnRH neurons to kisspeptin.

• Assess GnRH release from hypothalamic explants.

In Vivo Rescue Experiments:

• Test whether administration of GnRH can rescue reproductive defects in Kiss1r mutant mice.

• This approach can distinguish between defects in GnRH neuron function versus peripheral reproductive tissues.

How should researchers address contradictory findings regarding Kiss1r localization in different tissues?

When confronting contradictory findings regarding Kiss1r localization, researchers should systematically address these discrepancies:

Methodological Differences Assessment:

• Compare antibody sources, specificity validation methods, and detection techniques.

• Evaluate fixation protocols, as different methods can affect epitope accessibility.

• Consider the sensitivity of detection methods used (e.g., chromogenic IHC versus immunofluorescence).

Tissue-Specific Expression Patterns:

• One study noted that KISS1R localization patterns were inconsistent with previous data, which indicated KISS1R on the acrosome rather than the membrane of spermatids .

• Expression patterns may differ based on developmental stage, as shown by the constitutive expression of Kiss1r mRNA in mouse testes from birth to postnatal week 12, while Kiss1 expression begins at week 4 .

Validation Through Multiple Approaches:

• Combine protein detection (IHC, Western blot) with mRNA localization (in situ hybridization).

• Use transgenic reporter systems as independent confirmation.

• Perform functional assays to confirm the physiological relevance of localization findings.

• Consider single-cell resolution techniques to resolve heterogeneous expression within tissues.

Control Experiments:

• Include appropriate positive controls (e.g., hypothalamus for KISS1R) .

• Perform adsorption tests by preincubating antibodies with immunogenic peptides at varying concentrations .

• Include knockout tissues when available to confirm antibody specificity.

What control experiments are essential when studying Kiss1r function in reproductive biology?

Essential control experiments for studying Kiss1r function include:

Antibody Validation Controls:

• Dilution series to determine optimal antibody concentration (e.g., 1:800,000 dilution ratio) .

• Preincubation with immunogenic peptides at varying concentrations (e.g., 10μM versus 100μM) .

• Negative controls using tissues without primary antibodies .

• Positive controls using tissues with known expression (e.g., hypothalamus for KISS1R) .

Signaling Pathway Verification:

• Pharmacological inhibitor controls to confirm pathway specificity.

• For example, using protein kinase A inhibitor RP-cAMP to suppress Br-cAMP-induced Kiss1 expression confirms the cAMP/PKA pathway involvement .

Developmental Controls:

• Age-matched controls are critical when studying developmental processes.

• Time-course studies from postnatal day 0 through adulthood to capture developmental changes in expression patterns .

Hormone Administration Controls:

• Vehicle controls for hormone treatments.

• Dose-response relationships to establish physiological relevance.

• Time-course experiments to distinguish between acute and chronic effects.

Genetic Model Controls:

• Heterozygous littermates as controls for homozygous knockout models.

• Cre-negative littermates as controls for conditional knockout models.

• Wild-type controls matched for genetic background, age, and sex.

How can researchers distinguish direct versus indirect effects of Kiss1r signaling?

Distinguishing direct from indirect effects of Kiss1r signaling requires strategic experimental approaches:

Cell-Specific Knockout Models:

• Generate conditional knockout mice in which Kiss1r is deleted only in specific cell types of interest.

• Compare phenotypes with global knockout to identify cell-autonomous effects.

Ex Vivo Systems:

• Isolate specific cell types or tissues and stimulate with kisspeptin in the absence of other tissues.

• This approach can reveal direct responsive cell types.

• For example, treating isolated primary mouse Leydig cells with LH demonstrated direct regulation of Kiss1 expression .

Temporal Analysis:

• Use rapid time-course experiments to identify immediate versus delayed responses.

• Direct effects typically occur within minutes to hours, while indirect effects may take longer.

Pathway Inhibition:

• Selectively block downstream signaling pathways to identify which are essential for specific outcomes.

• The cAMP/PKA pathway has been identified as important for Kiss1 expression in Leydig cells .

Combined Approach Example:

• Administer kisspeptin to wild-type mice and measure rapid LH increase.

• Repeat in mice with Kiss1r specifically deleted in GnRH neurons.

• Loss of LH response in the conditional knockout confirms direct action on GnRH neurons.

• Persistence of other phenotypes would suggest additional direct targets.

What are the key considerations when comparing Kiss1r function across different mouse strains?

When comparing Kiss1r function across mouse strains, researchers should consider several factors:

Genetic Background Effects:

• Different mouse strains can show varying baseline reproductive parameters.

• Backcross experimental animals to a consistent genetic background when possible.

• If using mixed backgrounds, ensure appropriate controls from each parental strain.

Developmental Timing Variations:

• Strains differ in puberty onset timing and reproductive development milestones.

• Document strain-specific developmental timelines as baseline data.

• Age-match precisely when comparing across strains.

Hormone Level Differences:

• Baseline hormone levels (LH, FSH, sex steroids) vary between strains.

• Measure strain-specific reference ranges before interpreting experimental results.

Expression Pattern Comparison:

• Quantify Kiss1r expression levels across tissues of interest in each strain.

• Use identical methodologies and reagents when comparing strains.

• Both mRNA (qRT-PCR) and protein (Western blot, IHC) quantification may be necessary.

Functional Response Variations:

• Dose-response relationships to kisspeptin may differ between strains.

• Establish strain-specific dose-response curves before comparative studies.

• Consider both sensitivity (EC50) and maximal response parameters.

Data Normalization Strategy:

• When comparing across strains, normalize data to strain-specific controls rather than absolute values.

• Consider using percent change from baseline rather than raw values.

• For developmental studies, align data based on developmental milestones rather than chronological age.